PMI Acquires Minority Stake in Egypt's Eastern Company

PMI by 2FIRSTS.ai
May.23.2024
PMI Acquires Minority Stake in Egypt's Eastern Company
PMI acquires minority stake in Egypt's leading tobacco manufacturer EAST.CA, exploring long-term cooperation in non-exclusive fields.

According to a report from Cairo-based media Egypttoday on May 22, Philip Morris International (PMI) announced on Wednesday that it has acquired a minority indirect stake in the Egyptian state-owned tobacco manufacturer Eastern Company (EAST.CA), totaling 14.7%.

 

Eastern Company is Egypt's largest cigarette manufacturer, producing products such as cigars and pipe tobacco. The company clarified that as part of this acquisition, PMI and Eastern are seeking to explore potential strategic areas of long-term collaboration in technology, manufacturing, and innovation on a non-exclusive basis. This includes heated tobacco products, paving the way for a smoke-free future in Egypt.

 

Fred de Wilde, President of the South Asia, Southeast Asia, Independent States of the Commonwealth, Middle East, and Africa Region, stated, "We look forward to exploring potential areas of collaboration with Eastern Company, including opportunities to provide Egyptian adult smokers with better alternatives to cigarettes.

 

In November 2923, Chemical Industry Holdings Corporation (CIHC) ultimately sold 30% of its subsidiary, state-owned tobacco manufacturer Eastern Company, for 164 billion Egyptian pounds. CIHC sold approximately 6.69 billion shares to the investment company Global Investment Holding, based in the United Arab Emirates (UAE).

 

Egypt is selling shares of 35 state-owned companies through issuing stocks to strategic investors, listing on the EGX, or a combination of both.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
Russian Lawmaker Says Bill on Full Vape Sales Ban Is Before State Duma
Russian Lawmaker Says Bill on Full Vape Sales Ban Is Before State Duma
Yaroslav Nilov, chair of the State Duma Committee on Labour, Social Policy and Veterans’ Affairs, said a bill proposing a full ban on vape sales is currently before the State Duma, though no final decision has yet been made. He said the initiative has been signed by representatives of almost all factions and noted that support for a full ban has also been voiced at the regional governor level. Nilov also said vape use in Russia is increasing while the age of consumers is declining.
Mar.12 by 2FIRSTS.ai
Product | GEEKBAR Expands High-Puff Lineup; CLR 50K and Clio X Highlight Displays and Transparent E-Liquid Tanks
Product | GEEKBAR Expands High-Puff Lineup; CLR 50K and Clio X Highlight Displays and Transparent E-Liquid Tanks
GEEKBAR has added two new vaping products on its official website. Both feature transparent e-liquid tanks and are rated for up to 50,000 puffs. The CLR 50K is equipped with a 17 ml e-liquid capacity, is labeled at 5% nicotine (50 mg/ml), and offers Normal and Pulse modes, while the Clio X carries a 16 ml capacity, a dual-screen display, and three output modes.
Feb.28 by 2FIRSTS.ai
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI Flags 2026 Headwinds from Japan Taxes, Sees Smoke-Free Growth Re-Accelerating Beyond in Earnings Call
PMI said on its latest earnings call that Japan’s tax cycle will weigh on 2026 performance, while smoke-free growth is expected to re-accelerate thereafter. The discussion also covered U.S. regulation, ZYN strategy and AI-driven efficiency.
Feb.07
Reynolds American launches U.S. investment plan: to invest $3.2 billion to expand capacity and advance a shift toward smokeless products
Reynolds American launches U.S. investment plan: to invest $3.2 billion to expand capacity and advance a shift toward smokeless products
Reynolds American says it will invest more than $3.2 billion across its U.S. operations by 2030. The investment began in 2024 and is expected to support more than 2,000 direct and indirect jobs. The company says the plan covers modernization and expansion of manufacturing facilities, scaling innovation and production, supply-chain initiatives and employee training, and also references its R&D spending and related site footprint.
Mar.06 by 2FIRSTS.ai
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai